On December 8, 2025, Wave Life Sciences will unveil interim data from its Phase 1 INLIGHT trial, focusing on WVE-007, a promising treatment for obesity. This article explores the trial's significance, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback